These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 33068587)

  • 1. Yangonin inhibits ethanol-induced hepatocyte senescence via miR-194/FXR axis.
    Dong R; Wang X; Wang L; Wang C; Huang K; Fu T; Liu K; Wu J; Sun H; Meng Q
    Eur J Pharmacol; 2021 Jan; 890():173653. PubMed ID: 33068587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Yangonin modulates lipid homeostasis, ameliorates cholestasis and cellular senescence in alcoholic liver disease via activating nuclear receptor FXR.
    Kong L; Dong R; Huang K; Wang X; Wang D; Yue N; Wang C; Sun P; Gu J; Luo H; Liu K; Wu J; Sun H; Meng Q
    Phytomedicine; 2021 Sep; 90():153629. PubMed ID: 34304130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oroxylin A inhibits ethanol-induced hepatocyte senescence via YAP pathway.
    Jin H; Lian N; Bian M; Zhang C; Chen X; Shao J; Wu L; Chen A; Guo Q; Zhang F; Zheng S
    Cell Prolif; 2018 Jun; 51(3):e12431. PubMed ID: 29318697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatoprotection of yangonin against hepatic fibrosis in mice via farnesoid X receptor activation.
    Wang X; Fu T; Wang J; Wang C; Liu K; Wu J; Sun H; Ma X; Sun P; Meng Q
    Int Immunopharmacol; 2019 Oct; 75():105833. PubMed ID: 31450152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective effects of yangonin from an edible botanical Kava against lithocholic acid-induced cholestasis and hepatotoxicity.
    Kong Y; Gao X; Wang C; Ning C; Liu K; Liu Z; Sun H; Ma X; Sun P; Meng Q
    Eur J Pharmacol; 2018 Apr; 824():64-71. PubMed ID: 29427579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NFATc4 mediates ethanol-triggered hepatocyte senescence.
    Wu R; Wang X; Shao Y; Jiang Y; Zhou Y; Lu C
    Toxicol Lett; 2021 Oct; 350():10-21. PubMed ID: 34192554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Curcumin attenuates ethanol-induced hepatic steatosis through modulating Nrf2/FXR signaling in hepatocytes.
    Lu C; Zhang F; Xu W; Wu X; Lian N; Jin H; Chen Q; Chen L; Shao J; Wu L; Lu Y; Zheng S
    IUBMB Life; 2015 Aug; 67(8):645-58. PubMed ID: 26305715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Yangonin protects against cholestasis and hepatotoxity via activation of farnesoid X receptor in vivo and in vitro.
    Gao X; Fu T; Wang C; Ning C; Liu K; Liu Z; Sun H; Ma X; Huo X; Yang X; Zou M; Meng Q
    Toxicol Appl Pharmacol; 2018 Jun; 348():105-116. PubMed ID: 29660435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of Cellular Senescence by miR-34a in Alcoholic Liver Injury.
    Wan Y; McDaniel K; Wu N; Ramos-Lorenzo S; Glaser T; Venter J; Francis H; Kennedy L; Sato K; Zhou T; Kyritsi K; Huang Q; Annable T; Wu C; Glaser S; Alpini G; Meng F
    Am J Pathol; 2017 Dec; 187(12):2788-2798. PubMed ID: 29128099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Yangonin protects against non-alcoholic fatty liver disease through farnesoid X receptor.
    Dong R; Yang X; Wang C; Liu K; Liu Z; Ma X; Sun H; Huo X; Fu T; Meng Q
    Phytomedicine; 2019 Feb; 53():134-142. PubMed ID: 30668392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Yangonin protects against estrogen-induced cholestasis in a farnesoid X receptor-dependent manner.
    Dong R; Wang J; Gao X; Wang C; Liu K; Wu J; Liu Z; Sun H; Ma X; Meng Q
    Eur J Pharmacol; 2019 Aug; 857():172461. PubMed ID: 31220436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Schaftoside alleviates HFD-induced hepatic lipid accumulation in mice via upregulating farnesoid X receptor.
    Liu M; Zhang G; Wu S; Song M; Wang J; Cai W; Mi S; Liu C
    J Ethnopharmacol; 2020 Jun; 255():112776. PubMed ID: 32205261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of farnesoid X receptor attenuates hepatic injury in a murine model of alcoholic liver disease.
    Wu W; Zhu B; Peng X; Zhou M; Jia D; Gu J
    Biochem Biophys Res Commun; 2014 Jan; 443(1):68-73. PubMed ID: 24269813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bruceine A alleviates alcoholic liver disease by inhibiting AIM2 inflammasome activation via activating FXR.
    Li L; Xu S; Wang W; Li X; Wang H; Yang Q; Wang C; Gu J; Luo H; Meng Q
    Phytomedicine; 2024 Jul; 130():155693. PubMed ID: 38763006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dihydroartemisinin protects against alcoholic liver injury through alleviating hepatocyte steatosis in a farnesoid X receptor-dependent manner.
    Xu W; Lu C; Yao L; Zhang F; Shao J; Zheng S
    Toxicol Appl Pharmacol; 2017 Jan; 315():23-34. PubMed ID: 27939985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-194 inhibition improves dietary-induced non-alcoholic fatty liver disease in mice through targeting on FXR.
    Nie H; Song C; Wang D; Cui S; Ren T; Cao Z; Liu Q; Chen Z; Chen X; Zhou Y
    Biochim Biophys Acta Mol Basis Dis; 2017 Dec; 1863(12):3087-3094. PubMed ID: 28951211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Farnesoid X receptor regulates forkhead Box O3a activation in ethanol-induced autophagy and hepatotoxicity.
    Manley S; Ni HM; Williams JA; Kong B; DiTacchio L; Guo G; Ding WX
    Redox Biol; 2014; 2():991-1002. PubMed ID: 25460735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ZNF281 drives hepatocyte senescence in alcoholic liver disease by reducing HK2-stabilized PINK1/Parkin-mediated mitophagy.
    Lu C; Ge T; Shao Y; Cui W; Li Z; Xu W; Bao X
    Cell Prolif; 2023 Mar; 56(3):e13378. PubMed ID: 36514923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA 122, Regulated by GRLH2, Protects Livers of Mice and Patients From Ethanol-Induced Liver Disease.
    Satishchandran A; Ambade A; Rao S; Hsueh YC; Iracheta-Vellve A; Tornai D; Lowe P; Gyongyosi B; Li J; Catalano D; Zhong L; Kodys K; Xie J; Bala S; Gao G; Szabo G
    Gastroenterology; 2018 Jan; 154(1):238-252.e7. PubMed ID: 28987423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Curcumol inhibits ferritinophagy to restrain hepatocyte senescence through YAP/NCOA4 in non-alcoholic fatty liver disease.
    Qi X; Song A; Ma M; Wang P; Zhang X; Lu C; Zhang J; Zheng S; Jin H
    Cell Prolif; 2021 Sep; 54(9):e13107. PubMed ID: 34346124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.